Log in to save to my catalogue

H1:IC31 vaccination is safe and induces long-lived TNF-[alpha]+IL-2+CD4 T cell responses in M. tuber...

H1:IC31 vaccination is safe and induces long-lived TNF-[alpha]+IL-2+CD4 T cell responses in M. tuber...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1846812916

H1:IC31 vaccination is safe and induces long-lived TNF-[alpha]+IL-2+CD4 T cell responses in M. tuberculosis infected and uninfected adolescents: A randomized trial

About this item

Full title

H1:IC31 vaccination is safe and induces long-lived TNF-[alpha]+IL-2+CD4 T cell responses in M. tuberculosis infected and uninfected adolescents: A randomized trial

Publisher

Kidlington: Elsevier Limited

Journal title

Vaccine, 2017-01, Vol.35 (1), p.132

Language

English

Formats

Publication information

Publisher

Kidlington: Elsevier Limited

More information

Scope and Contents

Contents

Background Control of the tuberculosis epidemic requires a novel vaccine that is effective in preventing tuberculosis in adolescents, a key target population for vaccination against TB. Methods Healthy adolescents, stratified byM. tuberculosis-infection status, were enrolled into this observer-blinded phase II clinical trial of the protein-subunit...

Alternative Titles

Full title

H1:IC31 vaccination is safe and induces long-lived TNF-[alpha]+IL-2+CD4 T cell responses in M. tuberculosis infected and uninfected adolescents: A randomized trial

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_1846812916

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1846812916

Other Identifiers

ISSN

0264-410X

E-ISSN

1873-2518

DOI

10.1016/j.vaccine.2016.11.023

How to access this item